EurekAlert! -
16 Jun 2020 06:00
(University at Buffalo) A study led by a UB researcher found that a drug called golimumab preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings from a Phase 2 study.
Share this Article